Ganirelix Acetate (Organon USA Inc.)
Welcome to the PulseAid listing for the Ganirelix Acetate drug offered from Organon USA Inc.. This Decreased GnRH Secretion [PE],Gonadotropin Releasing Hormone Antagonist [EPC],Gonadotropin Releasing Hormone Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Organon USA Inc. |
NON-PROPRIETARY NAME: | Ganirelix Acetate |
SUBSTANCE NAME: | GANIRELIX ACETATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased GnRH Secretion [PE],Gonadotropin Releasing Hormone Antagonist [EPC],Gonadotropin Releasing Hormone Receptor Antagonists [MoA] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1999-07-29 |
END MARKETING DATE: | 0000-00-00 |
Ganirelix Acetate HUMAN PRESCRIPTION DRUG Details:
Item Description | Ganirelix Acetate from Organon USA Inc. |
LABELER NAME: | Organon USA Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(ug/.5mL) |
START MARKETING DATE: | 1999-07-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0052-0301_a6451f5e-660b-4ae2-93ac-af6902720278 |
PRODUCT NDC: | 0052-0301 |
APPLICATION NUMBER: | NDA021057 |
Other GANIRELIX ACETATE Pharmaceutical Manufacturers / Labelers: